Pharmaceuticals
One week after Netherlands defeat Biogen takes the win in Germany
Two days ago, market exclusivity for Biogen's multiple sclerosis drug Tecfidera expired in Europe. However, Düsseldorf Regional Court has prohibited v
...
3 February 2025 by Mathieu Klos